2017 AFHS Drug Information compendium has been released
The American Society of Hospital Pharmacists (ASHP) recently announced that a new AHFS Drug Information (AHFS DI) has been released. Read More »
The American Society of Hospital Pharmacists (ASHP) recently announced that a new AHFS Drug Information (AHFS DI) has been released. Read More »
The U.S. Food and Drug Administration has approved Siliq (brodalumab) as a treatment for adults with moderate-to-severe plaque psoriasis. Read More »
The American Society of Health-System Pharmacists has awarded 11 pharmacy students with both recognition and a cash reward for their excellence in their education, both on campus and pharmacy practice. Read More »
PharmaCyte Biotech, Inc., announced that they would be winning the 2017 Buzz of BIO "Pipelines of Promise" award prior to the 2017 BIO International Convention. Read More »
The American Society of Health-System Professionals (ASHP) recently announced that Michael Cohen, operations officer for the investigations branch of the Department of Health and Human Services (HHS) Office of Inspector General (OIG) in Washington, D.C., believes clinicians need to not just look at opioids but also at non-controlled drugs when trying to understand drug abuse. Read More »
The American Society of Health-System Professionals recently launched a pharmacy project aimed at training emergency medical services and law enforcement personnel on how to deliver naloxone to opioid-overdosed individuals. Read More »
The American Society of Health-System Professionals recently announced that the United States updated the Common Rule, a federal regulation that supports research involving human subjects. Read More »
The U.S. Food and Drug Administration has approved two applications for treatments of hepatitis C in children. Read More »
Ingrezza (valbenazine) has been approved by the Food and Drug Administration for the treatment of tardive dyskinesia in adults. Read More »
Sanofi and Regeneron Pharmaceuticals Inc.'s Dupixent injection has been approved by the U.S. Food and Drug Administration (FDA) for use treating adults with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies. Read More »
Panacea Pharmaceuticals Inc. presented its paper, "Improved Detection of Cancer Specific Serum Exosomal Aspartyl (Asparaginyl) beta Hydroxylase," and its findings on the company's multi-cancer HAAH exosome detection assay during the annual American Association for Cancer Research meeting in Washington, D.C. April 1-5. Read More »
The paper "Radioimmunotherapy for Acute Myeloid Leukemia Targeting Human Aspartyl (Asparaginyl) β-Hydroxylase” was presented at the American Association for Cancer Research (AACR) meeting by Panacea Pharmaceuticals on April 3. Read More »
Senators pushing for changes to Medicare Part D drug pricing reporting requirements should be wary of messing with the program, according to a former administrator of the Centers for Medicare and Medicaid Services. Read More »
The American Society of Health-System Pharmacists recently released “The Effective Pharmacy Preceptor,” a reference to assist pharmacists in training students and residents through experiential education techniques. Read More »
Pharmacists in Maine are seeking an end to direct and indirect remuneration fees. Read More »
The American Society of Health-System Pharmacists (ASHP) recently announced that the current Alabama legislature session is seeking to attempt to have the state codify collaborative drug therapy management (CDMT) as part of pharmacy practice. Read More »
The U.S. Food and Drug Administration has approved Noctivia nasal spray for adults who deal with nocturnal polyuria, a condition that causes overproduction of urine during the night. Read More »
According to a recent PRNewswire release, CVS Pharmacy is the first national retail pharmacy chain to remove trans fat from their store brand food products. Read More »
3M Drug Delivery Systems will continue its collaboration with Panacea Pharmaceuticals Inc., this time working on a new phase in its study of an investigational therapeutic cancer vaccine that would be delivered to the dermis via 3M's Hollow Microstructured Transdermal System. Read More »
Precision for Value and the National Committee for Quality Assurance have partnered to integrate data collected in the Healthcare Effectiveness Data and Information Set into the quality measuring tool Qnav. Read More »